• SENSEX 74,294.96
    -19.63 (--0.03%)
  • BANKNIFTY 56,358.70
    302.95 (+0.54%)
  • HDFC Bank
    733.50 1,020.35(%)
  • ITC
    262.20 256.25(%)
  • The Bombay Burmah
    1,531.60 2,135.00(%)
  • Rentomojo
    492.20 480.00(%)
  • Glass Wall Syst.
    304.50 304.50(%)
  • Multi Comm. Exc.
    3,232.00 1,545.65(%)
  • UltraTech Cem.
    10,670.00 10,329.00(%)
  • Adani Total Gas
    674.80 859.70(%)
  • EIH
    320.50 414.90(%)
  • Bajaj Finance
    1,036.10 1,177.60(%)
  • Lords Mark Industries
    89.68 669.70(%)
  • Meesho
    219.80 254.65(%)
  • Syrma SGS Tech.
    1,764.95 1,764.95(%)
  • Aditya Birla Cap
    404.25 430.55(%)
  • Raksan Transformers
    286.65 286.65(%)
  • Atul
    6,195.10 7,198.20(%)
  • Karamtara Engg.
    378.20 378.20(%)
  • TCS
    2,101.00 1,976.00(%)
  • Billionbrains
    195.50 227.00(%)
  • Tata Chemicals
    688.00 581.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Asston Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 94417.0
  • ISIN : INE0SJX01015
108.50 0 (-0.41%)
  • As on 20 Sep 2026 (EOD)

  • Today’s Low

    106.55

  • Today’s High

    108.50

  • Open

    107.50

  • Perv Close

    108.95

  • 52W Low

    60.00

  • 52W High

    126.10

Key Indicators

  • P/E(TTM)

    30.31

  • Mar.Cap (₹Cr.)

    118.51

  • Div & Yield %

    0.00

  • Book Value(₹)

    60.96

  • Debt-Equity Ratio

    -0.41

  • AGM Date

    18-Sep-2026

  • EPS

    3.58

  • P/E Ratio

    30.31

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    118.51

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.92

  • BV (₹)

    61.00

  • Sales( ₹ in Cr.)

    25.47

  • NP (in Cr.)

    3.91

  • NP Var(%)

    3.0

  • Div%

    0.0

  • CPS (₹)

    3.90

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    118.51

  • 52 Week High

    126.10

  • 52 Week Low

    60.00

  • Price BSE

    109.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    118.51

  • P/C Ratio

    28.10

  • P/E Ratio

    30.40

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 25.47 25.04 16.03 6.54 9.60 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 25.47 25.04 16.03 6.54 9.60 -
Other Income 6.12 0.57 0.25 0.65 0.96 -
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -
Total Income 31.59 25.61 16.28 7.19 10.56 -
EXPENDITURE :            
Raw Materials 17.41 14.14 9.75 2.68 6.70 -
Power and Fuel Cost 0.17 0.14 0.01 0.00 0.00 -
Employee Cost 1.62 1.06 0.19 0.23 0.26 -
Other Manufacturing Expenses 0.55 0.21 0.12 0.67 0.98 -
Selling and Administration Expenses 4.99 3.17 2.13 1.42 2.00 -
Miscellaneous Expenses 1.29 0.87 0.01 0.02 0.01 -
Employee Benefit Expenses 1.62 1.06 0.19 0.23 0.26 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 26.03 19.60 12.20 5.02 9.95 -
Operating Profit 5.55 6.01 4.07 2.17 0.60 -
Interest 0.63 0.95 0.76 0.72 0.43 -
Gross Profit 4.92 5.06 3.31 1.45 0.17 -
Depreciation 0.32 0.04 0.06 0.04 0.01 -
Profit Before Tax 4.60 5.02 3.25 1.41 0.16 -
Current Tax 0.62 1.22 0.81 0.34 0.03 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.11 -0.06 0.01 0.02 0.02 -
Reported Net Profit 3.87 3.85 2.43 1.06 0.11 -
Extraordinary Items -0.05 0.07 0.00 0.00 0.00 -
Adjusted Net Profit 3.92 3.78 2.43 1.06 0.11 -
Adjustment below Net Profit 0.00 -2.53 0.00 0.00 0.00 -
P & L Balance brought forward 4.76 3.44 1.01 0.23 0.12 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 8.63 4.76 3.44 1.29 0.23 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 4.54 6.14 31.01 15.09 1.58 -
Earnings Per Share(Adj)-Unit Curr 4.54 - - - - -
Book Value 45.65 17.60 91.63 28.37 13.28 -
Book Value(Adj)-Unit Curr 45.65 - - - - -

Shareholding Pattern

  • Promoter Group

    50.66%

  • Public Share Holding

    49.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,312,480 50.66 4,312,480 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,312,480 50.66 4,312,480 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 144,650 1.70 144,650 17
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 95,200 1.12 95,200 9
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 99,293 1.17 99,293 40
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,524,168 17.91 1,524,168 561
Individuals holding nominal share capital up to Rs. 1 lakh 2,336,569 27.45 2,336,569 31
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,199,880 49.34 4,199,880 658
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,512,360 100.00 8,512,360 661

Company Background

Asston Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Asston Pharmaceuticals Ltd
  • BSE Code : 94417.0
  • ISIN : INE0SJX01015

  • Incorporation Year

    2019

  • Registered Office

    4th Flr Office No.A-431 Balaji
    Bhavan Plot No.42A Sec-11 CBD, Mumbai,
    Maharashtra-400614

  • Telephone

    +91 22 4973 1411/+91 22 4973 1419

  • FAX

  • Chairman

  • Managing Director

    Ashish Narayan Sakalkar

  • Company Secretary

    Vandana Mishra

  • Auditor

    Doshi Doshi & Co/Panchal S K & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Maashitla Securities Pvt Ltd
    451 Krishna Apra Bus,
    Netaji Subhash Place,Pitampura
    Mumbai - New Delhi-110034

Asston Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Asston Pharmaceu 108.50 31.58 25.47 30.65 16.71
Abbott India 27,273.30 7,217.19 6,929.05 35.89 43.78
Astrazeneca Phar 6,751.40 2,304.07 2,275.58 99.50 27.86
Glaxosmi. Pharma 2,851.85 3,932.76 3,790.20 45.56 58.17
Novartis India 2,057.50 393.10 354.33 51.96 15.94
Cipla 1,371.45 20,102.60 18,979.95 36.04 13.88
Bliss GVS Pharma 680.40 773.53 729.81 63.23 12.51
Amrutanjan Healt 493.65 520.13 502.55 26.44 24.16
Fermenta Biotec. 475.75 474.15 450.25 22.21 18.77
Guj. Themis Bio. 427.65 168.25 165.82 114.34 18.05
Ambalal Sarabhai 40.45 19.52 3.94 74.91 6.77